Relationship between sex and immune checkpoint inhibitors in urothelial carcinoma and renal cell carcinoma
- PMID: 37410104
- DOI: 10.1007/s00345-023-04497-7
Relationship between sex and immune checkpoint inhibitors in urothelial carcinoma and renal cell carcinoma
Comment on
-
Impact of sex on the efficacy of immune checkpoint inhibitors in kidney and urothelial cancers: a systematic review and meta-analysis.World J Urol. 2023 Jul;41(7):1763-1774. doi: 10.1007/s00345-023-04412-0. Epub 2023 May 20. World J Urol. 2023. PMID: 37209143 Free PMC article.
References
-
- Yanagisawa T, Kawada T, Quhal F et al (2023) Impact of sex on the efficacy of immune checkpoint inhibitors in kidney and urothelial cancers: a systematic review and meta-analysis. World J Urol. https://doi.org/10.1007/s00345-023-04412-0 - DOI - PubMed - PMC
-
- Yuan Y, Liu L, Chen H et al (2016) Comprehensive characterization of molecular differences in cancer between male and female patients. Cancer Cell 29:711–722. https://doi.org/10.1016/j.ccell.2016.04.001 - DOI - PubMed - PMC
-
- Song Y, Qin C, Zhang C et al (2023) GNRH family genes contributed to gender-specific disparity of bladder cancer prognosis through exerting opposite regulatory roles between males and females. J Cancer Res Clin Oncol. https://doi.org/10.1007/s00432-023-04640-2 - DOI - PubMed - PMC
-
- Zhang X, Cheng L, Gao C et al (2023) Androgen signaling contributes to sex differences in cancer by inhibiting NF-κB activation in T cells and suppressing antitumor immunity. Cancer Res 83:906–921. https://doi.org/10.1158/0008-5472.CAN-22-2405 - DOI - PubMed
-
- Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors) (2022) Cochrane handbook for systematic reviews of interventions version 6.3. Cochrane 2022. http://www.training.cochrane.org/handbook . Accessed Feb 2022
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
